Follow
Marco Mor
Marco Mor
University of Parma, UniversitÓ degli Studi di Parma
Verified email at unipr.it
Title
Cited by
Cited by
Year
Modulation of anxiety through blockade of anandamide hydrolysis
S Kathuria, S Gaetani, D Fegley, F Vali˝o, A Duranti, A Tontini, M Mor, ...
Nature medicine 9 (1), 76-81, 2003
15902003
An endocannabinoid mechanism for stress-induced analgesia
AG Hohmann, RL Suplita, NM Bolton, MH Neely, D Fegley, R Mangieri, ...
Nature 435 (7045), 1108-1112, 2005
8302005
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
7342005
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamideá…
D Fegley, S Gaetani, A Duranti, A Tontini, M Mor, G Tarzia, D Piomelli
Journal of Pharmacology and Experimental Therapeutics 313 (1), 352-358, 2005
4622005
Pharmacological profile of the selective FAAH inhibitor KDS‐4103 (URB597)
D Piomelli, G Tarzia, A Duranti, A Tontini, M Mor, TR Compton, O Dasse, ...
CNS drug reviews 12 (1), 21-38, 2006
4042006
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress
M Bortolato, RA Mangieri, J Fu, JH Kim, O Arguello, A Duranti, A Tontini, ...
Biological psychiatry 62 (10), 1103-1110, 2007
3662007
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
JR Clapper, G Moreno-Sanz, R Russo, A Guijarro, F Vacondio, A Duranti, ...
Nature neuroscience 13 (10), 1265-1270, 2010
3442010
Cyclohexylcarbamic acid 3 ‘-or 4 ‘-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure− activity relationships, andá…
M Mor, S Rivara, A Lodola, PV Plazzi, G Tarzia, A Duranti, A Tontini, ...
Journal of medicinal chemistry 47 (21), 4998-5008, 2004
3192004
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus
JK Makara, M Mor, D Fegley, SI Szabˇ, S Kathuria, G Astarita, A Duranti, ...
Nature neuroscience 8 (9), 1139-1141, 2005
2592005
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation
C Solorzano, C Zhu, N Battista, G Astarita, A Lodola, S Rivara, M Mor, ...
Proceedings of the National Academy of Sciences 106 (49), 20966-20971, 2009
2352009
A catalytically silent FAAH-1 variant drives anandamide transport in neurons
J Fu, G Bottegoni, O Sasso, R Bertorelli, W Rocchia, M Masetti, A Guijarro, ...
Nature neuroscience 15 (1), 64-69, 2012
2062012
Design, synthesis, and structure− activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors
G Tarzia, A Duranti, A Tontini, G Piersanti, M Mor, S Rivara, PV Plazzi, ...
Journal of medicinal chemistry 46 (12), 2352-2360, 2003
2052003
The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice
R Russo, J LoVerme, G La Rana, TR Compton, J Parrott, A Duranti, ...
Journal of Pharmacology and Experimental Therapeutics 322 (1), 236-242, 2007
2012007
L718Q mutation as new mechanism of acquired resistance to AZD9291 in EGFR-mutated NSCLC
M Bersanelli, R Minari, P Bordi, L Gnetti, C Bozzetti, A Squadrilli, ...
Journal of thoracic oncology 11 (10), e121-e123, 2016
1562016
The Hippo pathway and YAP/TAZ–TEAD protein–protein interaction as targets for regenerative medicine and cancer treatment: Miniperspective
M Santucci, T Vignudelli, S Ferrari, M Mor, L Scalvini, ML Bolognesi, ...
Journal of medicinal chemistry 58 (12), 4857-4873, 2015
1562015
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice
J LoVerme, A Duranti, A Tontini, G Spadoni, M Mor, S Rivara, N Stella, ...
Bioorganic & medicinal chemistry letters 19 (3), 639-643, 2009
1212009
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices
AR King, A Duranti, A Tontini, S Rivara, A Rosengarth, JR Clapper, ...
Chemistry & biology 14 (12), 1357-1365, 2007
1212007
2-[N-Acylamino(C1−C3)alkyl]indoles as MT1 Melatonin Receptor Partial Agonists, Antagonists, and Putative Inverse Agonists
G Spadoni, C Balsamini, A Bedini, G Diamantini, B Di Giacomo, A Tontini, ...
Journal of medicinal chemistry 41 (19), 3624-3634, 1998
1201998
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand
R Ochoa-Sanchez, S Comai, B Lacoste, FR Bambico, ...
Journal of Neuroscience 31 (50), 18439-18452, 2011
1192011
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity
C Carmi, A Cavazzoni, V Zuliani, A Lodola, F Bordi, PV Plazzi, RR Alfieri, ...
Bioorganic & medicinal chemistry letters 16 (15), 4021-4025, 2006
1172006
The system can't perform the operation now. Try again later.
Articles 1–20